Unicycive Therapeutics Inc (UNCY)

Finanzdaten der Unicycive Therapeutics Inc-Aktie (UNCY)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	20.18%10.14	8.44	7.22	7.34	6.96
Research and Development	73.49%2.79	1.61	2.25	2.96	1.75
Operating Income/Loss	20.18%-10.14	-8.44	-7.22	-7.34	-6.96
Nonoperating Income/Loss	291.93%8.42	-4.39	-7.44	1.33	0.52
	86.57%-1.72	-12.82	-14.67	-6.01	-6.45
Attributable To Parent	86.57%-1.72	-12.82	-14.67	-6.01	-6.45
Available To Common Stockholders, Basic	86.57%-1.72	-12.82	-14.67	-6.01	-6.45
Basic Average Shares	12.59%26.92	23.91	-	18.07	12.30
Diluted Average Shares	12.59%26.92	23.91	-	18.07	12.30
Basic Earnings Per Share	88.89%-0.06	-0.54	-	-0.33	-0.52
Diluted Earnings Per Share	88.89%-0.06	-0.54	-	-0.33	-0.52